Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement
View/ Open
Author
Kowalski, Marek L.
Ansotegui, Ignacio
Aberer, Werner
Al-Ahmad, Mona
Akdis, Mubeccel
Ballmer-Weber, Barbara K.
Beyer, Kirsten
Blanca, Miguel
Brown, Simon
Bunnag, Chaweewan
Hulett, Arnaldo Capriles
Castells, Mariana
Chng, Hiok Hee
De Blay, Frederic
Ebisawa, Motohiro
Fineman, Stanley
Golden, David B. K.
Haahtela, Tari
Kaliner, Michael
Katelaris, Connie
Lee, Bee Wah
Makowska, Joanna
Muller, Ulrich
Mullol, Joaquim
Oppenheimer, John
Park, Hae-Sim
Parkerson, James
Passalacqua, Giovanni
Pawankar, Ruby
Renz, Harald
Rueff, Franziska
Sanchez-Borges, Mario
Sastre, Joaquin
Scadding, Glenis
Sicherer, Scott
Tantilipikorn, Pongsakorn
Tracy, James
van Kempen, Vera
Bohle, Barbara
Canonica, G Walter
Caraballo, Luis
Gomez, Maximiliano
Ito, Komei
Jensen-Jarolim, Erika
Larche, Mark
Melioli, Giovanni
Poulsen, Lars K.
Valenta, Rudolf
Zuberbier, Torsten
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1186/s40413-016-0122-3Metadata
Show full item recordCitation
Kowalski, M. L., I. Ansotegui, W. Aberer, M. Al-Ahmad, M. Akdis, B. K. Ballmer-Weber, K. Beyer, et al. 2016. “Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement.” The World Allergy Organization Journal 9 (1): 33. doi:10.1186/s40413-016-0122-3. http://dx.doi.org/10.1186/s40413-016-0122-3.Abstract
One of the major concerns in the practice of allergy is related to the safety of procedures for the diagnosis and treatment of allergic disease. Management (diagnosis and treatment) of hypersensitivity disorders involves often intentional exposure to potentially allergenic substances (during skin testing), deliberate induction in the office of allergic symptoms to offending compounds (provocation tests) or intentional application of potentially dangerous substances (allergy vaccine) to sensitized patients. These situations may be associated with a significant risk of unwanted, excessive or even dangerous reactions, which in many instances cannot be completely avoided. However, adverse reactions can be minimized or even avoided if a physician is fully aware of potential risk and is prepared to appropriately handle the situation. Information on the risk of diagnostic and therapeutic procedures in allergic diseases has been accumulated in the medical literature for decades; however, except for allergen specific immunotherapy, it has never been presented in a systematic fashion. Up to now no single document addressed the risk of the most commonly used medical procedures in the allergy office nor attempted to present general requirements necessary to assure the safety of these procedures. Following review of available literature a group of allergy experts within the World Allergy Organization (WAO), representing various continents and areas of allergy expertise, presents this report on risk associated with diagnostic and therapeutic procedures in allergology and proposes a consensus on safety requirements for performing procedures in allergy offices. Optimal safety measures including appropriate location, type and required time of supervision, availability of safety equipment, access to specialized emergency services, etc. for various procedures have been recommended. This document should be useful for allergists with already established practices and experience as well as to other specialists taking care of patients with allergies.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062928/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:29408265
Collections
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)